Feasibility Trial in Urban Pakistan for Community Engagement in Preventing Type II Diabetes and Risk Factors
Launched by BAQAI INSTITUTE OF DIABETOLOGY AND ENDOCRINOLOGY · Aug 22, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at ways to help prevent and control Type II Diabetes Mellitus, a common condition that affects how our bodies use sugar. The study is being conducted in urban Karachi, Pakistan, and aims to engage the community in this important health issue. By adapting and implementing a specific intervention, the researchers hope to see how effective these strategies can be in reducing the risk of diabetes among residents.
To participate in this trial, you need to be at least 20 years old and living in certain areas of Karachi. People who have normal blood sugar levels, those with borderline high levels, and individuals already diagnosed with diabetes are all encouraged to join. If you decide to participate, you should expect to attend scheduled meetings and activities designed to help you learn more about diabetes prevention and management. It’s also important to note that participants should be in good enough health to actively take part in the study. This is an exciting opportunity to contribute to community health while learning more about diabetes prevention!
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Individuals aged 20 years and above.
- • Participants residing in the randomized clusters of Karachi, Pakistan
- • Individuals willing to participate in the study and provide consent.
- • Both individuals with normoglycemia, intermediate hyperglycemia, and diabetes are encouraged to participate.
- • Participants who can attend the scheduled meetings and interventions as per the study protocol.
- Exclusion Criteria:
- • Individuals below the age of 20 years.
- • Individuals unwilling to provide consent for participation.
- • Participants with severe health conditions that may hinder their active involvement in the study.
- • Individuals with non-compliance with research protocols
About Baqai Institute Of Diabetology And Endocrinology
The Baqai Institute of Diabetology and Endocrinology is a leading clinical research organization dedicated to advancing the understanding and treatment of diabetes and endocrine disorders. With a commitment to innovative research and patient-centered care, the institute conducts rigorous clinical trials aimed at developing new therapies and improving existing treatment protocols. Its multidisciplinary team of experts collaborates closely with healthcare professionals and stakeholders to ensure high-quality research outcomes, while prioritizing the safety and well-being of participants. Through its initiatives, the Baqai Institute strives to contribute significantly to the field of endocrinology and enhance the quality of life for individuals affected by metabolic diseases.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Karachi, Sindh, Pakistan
Patients applied
Trial Officials
Abdul Basit, Director
Principal Investigator
Baqai Institute of Diabetes and Endocrinology
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported